3,4-Dihydro-3-oxo-2-quinoxalinecarboxylic acid
CAS: 1204-75-7
Ref. 3D-FD44241
1g | Discontinued | ||
2g | Discontinued | ||
5g | Discontinued | ||
10g | Discontinued | ||
500g | Discontinued |
Product Information
- 2-Quinoxalinecarboxylic acid, 3,4-dihydro-3-oxo-
- 2-Quinoxalinecarboxylic acid, 3,4-dihydro-3-oxo- (9CI)
- 2-Quinoxalinecarboxylic acid, 3-hydroxy-
- 2-Quinoxalinecarboxylic acid, 3-hydroxy- (8CI)
- 3-Hydroxyquinoxaline-2-carboxylic acid
- 3-Oxo-3,4-Dihydroquinoxaline-2-Carboxylate
- 3-Oxo-3,4-Dihydroquinoxaline-2-Carboxylic Acid
- 3-Oxo-4H-quinoxaline-2-carboxylic acid
- Nsc 34263
3,4-Dihydro-3-oxo-2-quinoxalinecarboxylic acid (3,4-DOQCA) is a supramolecular compound that has been shown to be activated by phosphorylation. The functional theory has been applied to the study of this compound, which has been shown to have an efflux effect on various drugs. 3,4-DOQCA is also able to form tautomers and change its molecular structure. FTIR spectroscopy revealed the presence of pyrazine-2 carboxylic acid in 3,4 DOQCA. It has been shown that this molecule can be used as a cochlear agent with a reaction time of 10 minutes under physiological conditions.
3,4-Dihydro-3-oxo-2-quinoxalinecarboxylic acid is synthesized from pyrazine-2 carboxylic acid and phosphorus pentoxide.